{"nctId":"NCT00442338","briefTitle":"Study of MK-0476 in Adult Patients With Acute Asthma (0476-334)","startDateStruct":{"date":"2007-03"},"conditions":["Asthma"],"count":91,"armGroups":[{"label":"Montelukast 7 mg","type":"EXPERIMENTAL","interventionNames":["Drug: montelukast sodium"]},{"label":"Montelukast 14 mg","type":"EXPERIMENTAL","interventionNames":["Drug: montelukast sodium"]},{"label":"Aminophylline 250 mg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: aminophylline hydrate"]}],"interventions":[{"name":"montelukast sodium","otherNames":["MK-0476"]},{"name":"montelukast sodium","otherNames":["MK-0476"]},{"name":"aminophylline hydrate","otherNames":["KyophyllinÂ® Injection 2.5%, FK05"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Adult participants with acute asthma attacks\n\nExclusion Criteria:\n\n* Participant has any known or suspected, acute or chronic cause for their pulmonary symptoms other than asthma (e.g., COPD, chronic heart failure, etc.).\n* Participant has a smoking habit (15 cigarettes per day) within a month prior to screening period, and/or has a smoking history (20 cigarettes per day) of more than 15 years.\n* Participant has a disease of the cardiovascular, hepatic, renal, hematologic systems, or other severe disease.","healthyVolunteers":false,"sex":"ALL","minimumAge":"15 Years","maximumAge":"75 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change From Baseline in Forced Expiratory Volume in One Second (FEV1) Within the First 60 Minutes After Administration","description":"The time weighted average change from Baseline in Forced Expiratory Volume in One Second (FEV1) over the first 60 minutes after study drug administration (average change FEV1 (0-60 min)). Baseline (pre-allocation) was the last measurement obtained during the screening period.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.07","spread":null},{"groupId":"OG001","value":"0.05","spread":null},{"groupId":"OG002","value":"0.06","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":30},"commonTop":["Glucose urine present","Diarrhea","Oedema","White blood cell count increased"]}}}